EVSB yields 4.66% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, EVSB + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EVSB + MRK for your $10,000?
EVSB aims to boost income while protecting capital by investing in investment grade, short-term securities. The fund primarily focuses on the banking sector. Alongside this focus, the fund also has stakes in US bonds, pooled-investments, asset and mortgage-backed securities. Most of the securities the fund holds are US dollar-denominated and up to a quarter of its total assets can be invested in foreign debt securities. The selection of the funds securities takes into account economic trends, comprehensive research, and applicable ESG factors. Additionally, EVSB has the flexibility to invest into below investment grade securities, but this is capped at 10%. The fund targets a portfolio duration of one year or less, which might extend in certain high volatility periods.
Full EVSB Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.